Mutations of CD79B (Case 1) encoding the B lymphocyte antigen receptor Ig-β component and of MYD88 (Case 6, 16, and 17) are well-known alterations in B-lymphoid malignancies, including PCNSL and leg-type cutaneous DLBCL. This evidence concerns the gene MYD88 and diffuse large B-cell lymphoma.